MIF and glioblastoma: Based on these information, we hypothesized that patients with GBM may have an increased prevalence of the regulatory MIF rs755622 nucleotide -173 G/C SNP (Figure 1B), which has been shown to be 1 factor with the ability to increase MIF expression.